{
    "title": "111_hr4689",
    "content": "The Act may be cited as the \"National Alzheimer's Project Act\" and establishes the Office of the National Alzheimer's Project. The Office of the National Alzheimer's Project is established in the Office of the Secretary of Health and Human Services. Its purpose is to accelerate the development of Alzheimer's treatments, create a national plan, coordinate healthcare for Alzheimer's patients, address health disparities, and collaborate internationally. The Office of the National Alzheimer's Project, established in the Office of the Secretary of Health and Human Services, aims to accelerate Alzheimer's treatments, create a national plan, coordinate healthcare, address health disparities, collaborate internationally, appoint a Director, oversee national plan creation, evaluate Federal programs, and submit reports to the President. The Director of the Office prepares the annual budget estimate and conducts an assessment of the nation's progress in addressing Alzheimer's. They also serve on the advisory board of the Office of Science and Technology to promote research efforts. Additionally, an Advisory Council on Alzheimer's Research and Treatment is established within the Office. The Advisory Council on Alzheimer's Research and Treatment, known as the Advisory Council, is comprised of federal members including designees from various health organizations like the Centers for Disease Control and Prevention, Administration on Aging, Centers for Medicare & Medicaid Services, Indian Health Service, National Institutes of Health, and the Surgeon General. The Advisory Council on Alzheimer's Research and Treatment includes federal members from organizations like the National Science Foundation and the Department of Veterans Affairs, as well as 12 expert members from outside the Federal Government, such as Alzheimer patient advocates, caregivers, health care providers, state health department representatives, and researchers with Alzheimer-related expertise. The Advisory Council on Alzheimer's Research and Treatment consists of federal members from various organizations and 12 external expert members, including Alzheimer patient advocates, caregivers, health care providers, state health department representatives, and researchers with Alzheimer-related expertise. The Council meets quarterly, provides advice to the Director of the Office, and submits an annual report. Meetings are open to the public. The Director of the Office provides recommendations for the annual report to Congress and an annually updated national plan. The annual report includes an evaluation of Alzheimer's research, clinical care, and programs. The Office will expire on December 31, 2025."
}